ADSSL1 Antikörper (N-Term) (FITC)
Kurzübersicht für ADSSL1 Antikörper (N-Term) (FITC) (ABIN2197094)
Target
Alle ADSSL1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 103-131, N-Term
-
Kreuzreaktivität
- Human, Maus
-
Kreuzreaktivität (Details)
- Calculated cross reactivity: Hu Mo
-
Produktmerkmale
- ADSSL1, NT (ADSSL1, ADSS1, Adenylosuccinate synthetase isozyme 1, Adenylosuccinate synthetase, basic isozyme, Adenylosuccinate synthetase, muscle isozyme, IMP-aspartate ligase 1) (FITC)
-
Aufreinigung
- Purified by Protein A affinity chromatography.
-
Immunogen
- ADSSL1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 103-131 amino acids from the N-terminal region of human ADSSL1.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working conditions should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, pH 7.2.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- -20°C
-
-
- ADSSL1 (Adenylosuccinate Synthase Like 1 (ADSSL1))
-
Andere Bezeichnung
- ADSSL1
-
NCBI Accession
- NP_689541, NP_954634
-
UniProt
- Q8N142
-
Pathways
- Ribonucleoside Biosynthetic Process
Target
-